Search
Close this search box.

Uncategorized

CABRI Announces Undergraduate Fellowships and Scholarship Program

by

The Cayman Biomedical Research Institute (CABRI) is pleased to announce that applications for our undergraduate fellowships and scholarship program are open. 

Undergraduate fellowships are available on a competitive basis to undergraduate students who have been offered an unpaid research position by a qualified principal investigator. Up to $5,000 per semester is available to each mentee-mentor team, with the entire amount paid as compensation to the undergraduate. The principal investigator will be responsible for the mentorship and guidance of the student during the period of the award. 

“These fellowships are an excellent training opportunity for undergraduates to expand their knowledge outside the lecture hall,” said Kourtney Goode, Academic Relations Coordinator at Cayman Chemical. “Hands-on research is an equally valuable learning experience that introduces a student to a potential career path and fosters the growth of their talents.” 

Undergraduate fellowship applications may be submitted on the CABRI website from August 22nd to September 18th, 2022, and awardees will be notified by October 16th, 2022.  

As part of CABRI’s commitment to help college-bound students continue their education after losing a parent or guardian to sinonasal undifferentiated carcinoma (SNUC) or B-cell lymphoma, scholarships are available to support the continued education of these students.  

Scholarship applications are accepted throughout the year and are available on the CABRI website.

CABRI is a nonprofit foundation that helps reduce the impact of rare diseases by funding research and supporting expanded opportunities for emerging scientists and families affected by these diseases. Contact CABRI with any questions about these funding opportunities.

CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods

by

The Cayman Biomedical Research Institute (CABRI) is pleased to announce a call for proposals that support essential research on specialized pro-resolving mediator (SPM) analytical methods.  

There is a critical need for basic research on analytical methods used for specialized pro-resolving mediators (SPMs). SPMs are a family of lipid metabolites derived from polyunsaturated fatty acids (PUFAs) that promote the resolution of inflammation and have been detected in several experimental models and human conditions. However, researchers using mass spectrometry-based methods have been in conflict with each other, and do not agree on how much, if any, SPMs are present in biologically relevant contexts. Hence, continued research on SPM analytical methods is necessary for this field to move forward.  

CABRI is offering research grants in amounts up to $100,000 to support this need. We encourage anyone seeking to provide clarity to SPM analytical methods to apply for these research grants. 

Research proposal applications may be submitted on the CABRI website. These applications will be reviewed on a rolling basis. 

CABRI is a nonprofit foundation that supports research on rare illnesses and orphan diseases. As part of CABRI’s commitment to the greater scientific community, CABRI awards research grants to academic scientists that address basic science research objectives with the highest unmet needs. 

See some of CABRI’s past research grant recipients here.  

Contact CABRI with any questions about this funding opportunity. 

Mackenzie Sederburg received the SNUC Scholarship for the 2019/2020 school year!

by

Mackenzie achieved an Exercise Science major and Psychology minor at Wayne State University. She is excited to continue her education and obtain her doctorate in Occupational Therapy. Her passion for OT stemmed from witnessing her father’s OT appointments when he was undergoing SNUC treatment during her youth.

Throughout her college career, Mackenzie has made her mark through participation in many organizations: Wayne State College Pre-PT/OT Club, Vice President of the Psi Chi International Honors Society in psychology, and the Love Your Melon organization supporting juvenile cancer funding. Congrats, Mackenzie

Mackenzie Sederburg received the SNUC Scholarship for the 2019/2020 school year!

Mackenzie achieved an Exercise Science major and Psychology minor at Wayne State University. She is excited to continue her education and obtain her doctorate in Occupational Therapy. Her passion for OT stemmed from witnessing her father’s OT appointments when he was undergoing SNUC treatment during her youth. Throughout her college career, Mackenzie has made her mark through participation in many organizations: Wayne State College Pre-PT/OT Club, Vice President of the Psi Chi International Honors Society in psychology, and the Love Your Melon organization supporting juvenile cancer funding. Congrats, Mackenzie!

Researchers Receive Grants from Sapphire North America and CABRI in Joint Effort to Help Scientists Return to Research

by

ANN ARBOR, MI, August 2, 2021 — Sapphire North America partnered with the Cayman Biomedical Research Institute (CABRI) to offer recovery grants to help re-engage the research of investigators affected by COVID-19 this past year. From the qualifying applicants, the following five researchers have been selected to receive $2,000 each in grant funds to support their work.

2021 Return to Research Grant Recipients

Elizabeth Delorme-Axford, Ph.D., is an Assistant Professor of Biochemistry at Oakland University who is launching an independent research program to identify the cellular and molecular mechanisms regulating autophagy. Her goal is to develop new therapeutics for human diseases associated with aberrant autophagy such as cancer, neurodegenerative diseases, and lysosomal storage disorders. She plans to use the funding to investigate post-transcriptional mechanisms regulating autophagy-related gene expression and autophagy activity with a focus on pseudouridine synthase 7-mediated pseudouridylation as a posttranscriptional RNA modification.

Jorgelina Calandria, Ph.D., is an Assistant Professor of Cell Biology and Anatomy and Neuroscience at Louisiana State University Health Sciences Center New Orleans who is interested in the mechanisms of neuroprotection exerted by bioactive lipids derived from docosahexaenoic acid (DHA). She focuses on age-related neurodegenerative diseases related with Parkinson’s disease and Lewy body dementia, seeking to counteract the effects of deregulated phospholipase A2 group VI in these pathologies by treating her acute and chronic rat models of Parkinsonian disorders with bioactive lipids.

Mariola Edelmann, Ph.D., is an Assistant Professor of Microbiology and Cell Science at the University of Florida who studies the roles of exosomes and lipid‐based extracellular signals in host‐pathogen interactions to design new methods for the prevention and treatment of Gram-negative infections. She plans to use the funding to purchase cannabinoid libraries to study the function of cannabinoids in the host response to Salmonella and other enteric infections. Dr. Edelmann also has a research collaboration to find new therapeutic treatments for Krabbe disease. She will use the same library in testing potential therapies for this leukodystrophy.

Pengda Liu, Ph.D., is an Assistant Professor of Biochemistry and Biophysics at the University of North Carolina at Chapel Hill who is searching for new therapeutic directions for cancer treatment by working to decipher aberrant cell signaling events as well as modification-mediated changes in the protein-protein interactome that contribute to tumorigenesis. His lab is planning to use their expertise in protein degradation to investigate if several SARS-CoV-2 viral proteins are targeted by the host E3 ubiquitin ligase Speckle-type BTB–POZ protein (SPOP), which is regulated by casein kinase I, and how that process can be reinforced as an approach to treat or block SARS-CoV-2 infection.

 

Carmen De Miguel, Ph.D., is an Assistant Professor of Medicine – Nephrology at the University of Alabama at Birmingham whose research program is focused on understanding how immune cells and immune mediators impact renal function and end‐organ damage during hypertension and diabetes. Her laboratory is investigating the role of endothelin‐1 in hypertension‐induced inflammation and end-stage organ damage, endothelin‐1 and kidney inflammation in diabetic kidney disease, and mechanisms involved in hyperoxia-induced kidney damage. They are also working to determine if sex differences in diabetic kidney disease are mediated by activation of different immune cell populations.

“COVID-19 has been a tremendous opportunity for those scientists already studying RNA viruses, vaccinations, and viral enzyme inhibitors, as well as those who could pivot their research from a related field to include the study of SARS-CoV-2,” said Dr. Kirk Maxey, President and Director of CABRI. “Unfortunately, lockdown prohibitions, the loss of cell lines and animal colonies, and institutionally limited working hours impaired investigators in all fields, including those with no prospect for new, COVID-related funding. Sapphire North America and CABRI want to provide a boost, especially to these worthy young investigators as they return full time to their labs.” The above recipients were selected based on the merits of their research and the proposed use of the grant funds to support their work.


About Sapphire North America
Sapphire North America is a distributor of specialized biochemical tools and reagents sourced from overseas suppliers, mainly in Europe and Asia. We offer scientists in North America a convenient, domestic source for unique products made around the world without the complications of customs clearance, currency conversion, and international ordering. Our dedication to our customers extends to our supplier relationships. As a distributor of life science research products, we provide marketing, sales, logistics services, and R&D opportunities to our international suppliers. We are actively seeking suppliers outside North America who are looking for a partner to help them expand in this important market.


About CABRI
Cayman Biomedical Research Institute (CABRI) is a nonprofit organization that supports research into the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development of therapeutics for these conditions. We also provide undergraduate research grants targeted primarily at students whose financial needs preclude them from taking unpaid internships in advanced academic laboratories. The application period for these grants opens in August each year. Grants range from $2,000 to $10,000 per PI/undergraduate team. To learn more or apply, visit www.cabrimed.org.

Get The Latest

Facebook Twitter Linkedin